date:Sep 19, 2012
's acquisition of immune support supplement maker Airborne in March.
Schiff attributed a 34% year-on-year increase in operating expenses to $27.1 million to increased marketing spend.
The company slightly raised its full-year net sales growth forecast from 40-43% to 43-46%.
Our brand building, innovation, and customer initiatives continue to drive MegaRed in heart health, Move Free in joint care, Airborne in immune support, and Digestive Advantage in probiotics, said Tarang Amin, Schiffs presi